// App-Quantinova.ai

783 : Breakthrough SARS-CoV-2 Infections and Predicting Severe Outcomes During Rituximab Therapy in Autoimmune Rheumatic Diseases

Researchers

Presenter

  • Md Yuzaiful Md Yusof

Principal Investigators

  • Jack Arnold

  • Benazir Saleem

  • Claire Vandevelde

  • Shouvik Dass

  • Sinisa Savic

  • Edward M Vital

  • Paul Emery

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • Medical Physics Department, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

  • Single Center

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved